Kaleidoscope Live!

Kaleidoscope Live!

By Maudsley LearningScienceSocial Sciences
Download on the App Store

Kaleidoscope Live! episodes

  • Kaleidoscope live! The dangers of being a woman in a man’s world and the placebo effect

    Title:

    In this episode, the Kaleidoscope Live! team discussed:

    • 95% of women report their PPE hampers their work: the dangers of being a woman in a man’s world
    • The citizen scientists who took part in psychedelic micro dosing study showed improved wellbeing and life satisfaction but, half of them were on the placebo.

      • They covered the sex and drugs, watch the recording for the rock and roll.


      Citations:

      Shansky, R. M., & Murphy, A. Z. (2021). Considering sex as a biological variable will require a global shift in science culture. Nature Neuroscience, 1-8. https://doi.org/10.1038/s41593-021-00806-8

      Szigeti, B, Kartner L, Blemings A et al. Self-blinding citizen science to explore psychedelic microdosing. eLife 2021; 10:e62878.

      44 min
    • Kaleidoscope live! Phenotyping, Relapse, and Racism

      Title: Phenotyping, Relapse, and Racism

      There is an impetus for the use of emerging technologies in both assessing and improving mental health, as well as in examining complex processes like recruitment practices.  In this Kaleidoscope Live! the team discuss the use of digital phenotyping for relapse in schizophrenia and the monitoring of discrimination in online recruitment.


      Citations:

      Henson, P, D’Mello, R, Vaidyam A et al. Anomaly detection to predict relapse risk in schizophrenia. Translational Psychiatry, 2021; 11:28. https://doi.org/10.1038/s41398-020-01123-7

      Hangartner, D., Kopp, D. & Siegenthaler, M. Monitoring hiring discrimination through online recruitment platforms. Nature 589, 572–576 (2021). https://doi.org/10.1038/s41586-020-03136-0

      37 min
    • Kaleidoscope live! COVID and Ketamine

      Title: COVID and Ketamine

      Citations:

      • Pan K-Y, Kok AA, Eikelenboom M, Horsfall M, Jörg F, Luteijn RA, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry 2021. Available from: https://doi.org/10.1016/S2215-0366(20)30491-0.
      • Aguilar-Valles, A., De Gregorio, D., Matta-Camacho, E. et al. Antidepressant actions of ketamine engage cell-specific translation via eIF4E. Nature (2020). https://doi.org/10.1038/s41586-020-03047-0
        • 38 min
      • Kaleidoscope live! The unsung hero that is statistics

        Title: This week the Kaleidoscope team are talking about the unsung hero that is statistics, the maths that influences what we deem important in research, and an exciting emerging idea in schizophrenia.


        Citations:

        Gelman, A., & Vehtari, A. (2020). What are the most important statistical ideas of the past 50 years?. arXiv preprint arXiv:2012.00174 

        Mealer RG, Williams SE, Daly MJ et al. Glycobiology and schizophrenia: a biological hypothesis emerging from genomic research. Molecular Psychiatry, 2020; 25:3129-3139.

        32 min
      • Kaleidoscope live! Mental health prevention

        Title: In the latest episode, the Kaleidoscope crew discuss moving mental health away from being a reactive field, exploring the possibilities of prevention in school and workplaces, and reflect on environmental green and blue prescriptions for the treatment of anxiety and depression.


        Citations:

        • Hoare E, Callaly E, Berk M. Can Depression Be Prevented? If So, How? JAMA Psychiatry, 2020; 77(11):1095-1096.
        • Tester-Jones, M., White, M.P., Elliott, L.R. et al. Results from an 18 country cross-sectional study examining experiences of nature for people with common mental health disorders. Sci Rep 10, 19408 (2020). https://doi.org/10.1038/s41598-020-75825-9
          • 36 min
        • Kaleidoscope live! Cannabis

          Title: Cannabis

          In this episode, the Kaleidoscope team talked all things marijuana including the use of cannabidiol to treat marijuana dependence, the history and lore of the drug,  and a major flaw in the marijuana supply informing US-based research.


          Citations:

          • Freeman, T. P., Hindocha, C., Baio, G., Shaban, N. D., Thomas, E. M., Astbury, D., … & Bloomfield, M. A. (2020). Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial. The Lancet Psychiatry, 7(10), 865-874.
          • Schwabe, A. L., Hansen, C. J., Hyslop, R. M., & McGlaughlin, M. E. (2019). Research grade marijuana supplied by the National Institute on Drug Abuse is genetically divergent from commercially available Cannabis. bioRxiv, 592725.
            • 34 min

          About Kaleidoscope Live!

          From the publisher's feed

          Three psychiatrists and a psychologist walk into a pub (or, in these unprecedented times, a Zoom meeting)….to talk science! Kaleidoscope Live takes you behind the scenes of the monthly British Journal…